Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo

BACKGROUND: Annual mass drug administrations (MDA) of ivermectin will strongly reduce Onchocerca volvulus microfilariae (mf) in the skin and in the onchocerciasis patients’ eyes. Ivermectin treatment will also affect the expression of immunity in patients, such that activated immune defenses may hel...

Descripción completa

Detalles Bibliográficos
Autores principales: Johanns, Saskia I., Gantin, Richard G., Wangala, Bawoubadi, Komlan, Kossi, Halatoko, Wemboo A., Banla, Meba, Karabou, Potchoziou, Luty, Adrian JF, Schulz-Key, Hartwig, Köhler, Carsten, Soboslay, Peter T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064110/
https://www.ncbi.nlm.nih.gov/pubmed/35503786
http://dx.doi.org/10.1371/journal.pntd.0010340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064110/
https://www.ncbi.nlm.nih.gov/pubmed/35503786
http://dx.doi.org/10.1371/journal.pntd.0010340

Ejemplares similares